EMEDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Electromedical Technologies, Inc

Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024

$0.00+0.00 (+9900.00%)

Close on Oct 19, 2026

Market cap: $68.10K
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Sep 30, 2024

Electromedical Technologies reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Electromedical Technologies's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Electromedical Technologies's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EMED.

Revenue growth-35.1% · median 30.0%

Gross margin75.1% · median 66.0%

Operating margin-109.6% · median -1.5%

Net margin-182.0% · median -1.6%

Company	Revenue	Growth
TCMD	$350.31M	+17.2%
SNWV	$44.02M	+12.7%
SNOA	$21.92M	+47.0%
NMTC	$9.47M	+42.8%
EMED	$922.01K	-35.1%
STME	–	–

Company

Exchange: OTC
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 6
Auditor: Dbbmckennon
SEC CIK: 1715819

Advertisement
300 × 250